AstrasZeneca deal or possible approvals of its Covid-19 drug Remdesivir may trigger the sharp increase to the upper bound of the daily trend.
SL below daily trend level.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
